A produ o de insulina artificial através da tecnologia do DNA recombinante para o tratamento de diabetes mellitus

Genetic Engineering has provided advances in medicine and the pharmaceutical industry with the creation ofrecombinant DNA technology (DNA from the combination of different sequences of DNAs belonging differentorganisms). For example, this technology is used in the production of artificial insulin through the bacteriumEscherichia coli, that is genetically modified so that there is capable of synthesizing this hormone. The application ofinsulin is the primary method used in the treatment of patients with Diabetes mellitus (DM), a chronic disease thatoccurs when the pancreas does not produce enough insulin or when the body does not effectively use the insulinproduced. With this technology in artificial insulin is produced in less time and on a larger scale, will benefit peoplewith diabetes, so this way can lead a normal life.